Search results for "Hazard"

showing 10 items of 1517 documents

Incidence and survival in late liver metastases of colorectal cancer

2014

Background and Aims Data concerning the risk of long-term liver metastasis following surgery of colorectal cancer in the general population are scarce. The 10-year incidence and prognosis of metachronous liver metastases remain unknown. Methods Among 4584 patients resected for cure for colorectal cancer recorded in two French digestive population-based cancer registries between 1985 and 2000, 602 presented metastases including liver metastases. Results The cumulated incidence of liver metastasis was 15% at 5 years and 17% at 10 years, and was mainly related to stage at diagnosis. The 10-year cumulative incidence was 6% for stage I and 30% for stage III. The hazard ratio was 3.2 [2.4–4.3] fo…

Oncologymedicine.medical_specialtyeducation.field_of_studyHepatologyRelative survivalbusiness.industryColorectal cancerPopulationHazard ratioGastroenterologyCancermedicine.diseaseCancer registryMetastasisInternal medicineMedicineCumulative incidencebusinesseducationJournal of Gastroenterology and Hepatology
researchProduct

Melanoma epidemiology, prognosis and trends in Latvia

2012

Background Melanoma incidence and mortality rates are increasing worldwide within the white population. Clinical and histological factors have been usually used for the prognosis and assessment of the risk for melanoma. Objectives The aim of the study was to describe the clinical and histopathological features of the cutaneous melanoma (CM) in the Latvian population, to test the association between melanoma features and patient survival, and to assess the time trends for melanoma incidence. Methods We undertook a descriptive, retrospective analysis of archive data of 984 melanoma patients treated at the largest oncological hospital of Latvia, Riga East University Hospital Latvian Oncology C…

Oncologymedicine.medical_specialtyeducation.field_of_studyProportional hazards modelbusiness.industryMortality rateIncidence (epidemiology)MelanomaPopulationDermatologymedicine.diseaseNodular melanomaSurgeryBreslow ThicknessInfectious DiseasesInternal medicineCutaneous melanomamedicineeducationbusinessJournal of the European Academy of Dermatology and Venereology
researchProduct

Supportive Efficacy Analyses for the Phase 3 Study of Temsirolimus Versus Investigator’s Choice Therapy for the Treatment of Patients with Relapsed o…

2008

Abstract Temsirolimus (Torisel®) is a specific inhibitor of the mTOR kinase with antitumor activity in patients with relapsed or refractory mantle cell lymphoma. In a phase 3, randomized, open-label study, patients treated with temsirolimus 175 mg weekly 3 times followed by 75 mg weekly (175/75-mg) had significantly longer progression-free survival (PFS) than those treated with investigator’s choice therapy (p-value temsirolimus: investigator’s choice = 0.0009; hazard ratio = 0.44; 97.5% CI = 0.25, 0.78; Hess et al. J Clin Oncol.2008, 28:abs 8513). Patients treated with temsirolimus 175 mg weekly 3 times followed by 25 mg weekly (175/25-mg) showed a trend towards longer PFS than those treat…

Oncologymedicine.medical_specialtyeducation.field_of_studyRandomizationbusiness.industryProportional hazards modelImmunologyPopulationHazard ratioPhases of clinical researchCell BiologyHematologymedicine.diseaseBiochemistryTemsirolimusSurgeryInternal medicineClinical endpointmedicinebusinesseducationProgressive diseasemedicine.drugBlood
researchProduct

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT pr…

2019

Summary Background There is an urgent need for more effective therapies for glioblastoma. Data from a previous unrandomised phase 2 trial suggested that lomustine-temozolomide plus radiotherapy might be superior to temozolomide chemoradiotherapy in newly diagnosed glioblastoma with methylation of the MGMT promoter. In the CeTeG/NOA-09 trial, we aimed to further investigate the effect of lomustine-temozolomide therapy in the setting of a randomised phase 3 trial. Methods In this open-label, randomised, phase 3 trial, we enrolled patients from 17 German university hospitals who were aged 18–70 years, with newly diagnosed glioblastoma with methylated MGMT promoter, and a Karnofsky Performance …

Oncologymedicine.medical_specialtyeducation.field_of_studyTemozolomidebusiness.industryPopulationHazard ratioMedizinGeneral MedicineLomustine030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawConcomitantInternal medicinemedicineClinical endpoint030212 general & internal medicineeducationbusinessChemoradiotherapymedicine.drugThe Lancet
researchProduct

Impact of Postoperative Complications on Survival and Recurrence After Resection of Colorectal Liver Metastases

2019

OBJECTIVE To study the effect of postoperative complications (POC) on overall survival (OS) and disease-free survival (DFS) after surgical resection of colorectal liver metastases (CRLM). SUMMARY BACKGROUND DATA Morbidity rates after liver resection can reach 45%. The negative impact of POC on oncologic outcomes has been reported in various types of cancer, especially colorectal. However, data on the consequences of POC after CRLM resection on long-term survival are scarce. METHODS Eligible studies examining the association between POC after CRLM resection and OS/DFS were sought using the PubMed and Web of Science databases. A random-effects model was used to calculate pooled effect estimat…

Oncologymedicine.medical_specialtymedicine.medical_treatmentSubgroup analysisResection03 medical and health sciencesPostoperative Complications0302 clinical medicineInternal medicinemedicineHepatectomyHumansSurvival rateSurvival analysisbusiness.industryLiver NeoplasmsHazard ratioCancermedicine.diseaseSurvival Rate030220 oncology & carcinogenesisMeta-analysis030211 gastroenterology & hepatologySurgeryNeoplasm Recurrence LocalHepatectomyColorectal NeoplasmsbusinessAnnals of Surgery
researchProduct

Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—A trial-level meta-analysis in PD-L1 selecte…

2021

BACKGROUND: The advent of immuno-oncology (IO) represented a breakthrough in non-small cell lung cancer (NSCLC) therapy over the last few years. However, establishing the optimal therapeutic options among programmed death-ligand 1 (PD-L1) selected subgroups still addresses an unmet need in the clinical setting. METHODS: We performed a systematic review and finally included eleven first-line randomized controlled trials to compare efficacy and safety outcomes among first-line IO treatment strategies versus standard platinum-based chemotherapy (CT) according to PD-L1 expression level (<1%, 1–49%, ≥50%). Pooled hazard ratios (HRs) and risk ratios (RRs) for progression-free survival (PFS), over…

Oncologymedicine.medical_specialtyprogrammed death-1/cytotoxic T-lymphocyte antigen 4 inhibitors (PD-1/CTLA-4 inhibitors)combined modality therapybusiness.industryHazard ratioCombined modality therapy; Immunotherapy; Meta-analysis; Non-small cell lung cancer (NSCLC); Programmed death-1/cytotoxic T-lymphocyte antigen 4 inhibitors (PD-1/CTLA-4 inhibitors)non-small cell lung cancer (NSCLC)Non-small cell lung cancer (NSCLC)medicine.diseaselaw.inventionDiscontinuationmeta-analysisOncologyRandomized controlled triallawRelative riskInternal medicineMeta-analysisMedicineOriginal ArticleimmunotherapybusinessLung cancerAdverse effect
researchProduct

Spatial risks and complex systems: methodological perspectives

2007

Research on risk and industrial catastrophes question the complexity theories. Besides the concepts of complexity which lead us to reconsider concepts of risk, hazard and vulnerability, we propose to think about more practical aspects, for example the modelling of human behaviour in crisis situations. The link between concepts as critical self-organization, emergence, bifurcation, and the methods in the Distributed Artificial Intelligence (DAI) used to model them is however difficult. In this paper, we present ongoing analysis on the key concepts of risk science, such as hazards and catastrophes. We propose to enrich them with complex systems theories. First, we present methodological persp…

Operations researchComputer science[SHS.GEO] Humanities and Social Sciences/Geographymedia_common.quotation_subject0211 other engineering and technologies0507 social and economic geographyComplex systemVulnerabilitypanicContext (language use)02 engineering and technologyIndustrial Accident[ SHS.GEO ] Humanities and Social Sciences/Geographycomplex systemsresilienceComputingMilieux_MISCELLANEOUSmedia_commonriskcomplexity theoriesStructure (mathematical logic)human behaviour05 social sciencesSpatial risks021107 urban & regional planning[SHS.GEO]Humanities and Social Sciences/GeographyHazardRisk perceptionRisk analysis (engineering)Psychological resilience050703 geography
researchProduct

A review of the application of the hazard analysis and critical control point system to salads served in the restaurant of Valencia University

2005

Operations researchbiologybusiness.industryComputer scienceCritical control pointHazard analysisFood safetybusinessbiology.organism_classificationValenciaIndustrial and Manufacturing EngineeringFood ScienceInternational Journal of Food Science and Technology
researchProduct

Substitution of hazardous substances for health and environment: lessons and experiences from European projects

1999

This paper deals with substitution of hazardous substances in production processes for environmental and health and safety reasons, with special reference to experiences of substitution of volatile organic compounds in paints and in concrete mould release agents. Substitution in this context is seen as a particular kind of technological transfer, in which the main value of the technology lies in its environmental and health and safety performances, as a contribution to industrial sustainability. The authors identify the main actors of the substitution process (industry, trade unions, NGOs, etc.), the role they play in such a process (promoter, target group, ally or opposer) and the scene i…

Organizational Behavior and Human Resource ManagementHazardous wasteIndustrial relationsSubstitution (logic)Production (economics)Operations managementBusinessEnvironmental planningOccupational safety and healthTransfer: European Review of Labour and Research
researchProduct

Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

2021

Abstract Background Little is known about characteristics of seasonal human coronaviruses (HCoVs) (NL63, 229E, OC43, and HKU1) after allogeneic stem cell transplantation (allo-HSCT). Methods This was a collaborative Spanish and European bone marrow transplantation retrospective multicenter study, which included allo-HSCT recipients (adults and children) with upper respiratory tract disease (URTD) and/or lower respiratory tract disease (LRTD) caused by seasonal HCoV diagnosed through multiplex polymerase chain reaction assays from January 2012 to January 2019. Results We included 402 allo-HSCT recipients who developed 449 HCoV URTD/LRTD episodes. Median age of recipients was 46 years (range,…

PNEUMONIAMalevirusesmedicine.medical_treatmentseasonal human coronavirusHematopoietic stem cell transplantationmedicine.disease_causeDISEASElaw.inventionCoronavirus OC43 HumanCLINICAL CHARACTERISTICSlawCoronavirus 229E HumanRisk FactorsImmunology and AllergyChildRespiratory Tract InfectionsNL63 INFECTIONSCoronavirusOUTCOMESRespiratory tract infectionsSYNCYTIAL VIRUSHazard ratioHematopoietic Stem Cell Transplantationvirus diseasesupper and lower respiratory tract diseaseHCoV-NL63HCoV-229Erespiratory systemMiddle AgedIntensive care unitHospitalizationimmunocompromisedsurgical procedures operativeInfectious Diseasesmedicine.anatomical_structureAcademicSubjects/MED00290Child PreschoolCohortFemaleSeasonsCoronavirus InfectionsRare cancers Radboud Institute for Health Sciences [Radboudumc 9]allogeneic hematopoietic stem cell transplantation; community-acquired respiratory virus; HCoV-229E; HCoV-HKU1; HCoV-NL63; HCoV-OC43; immunocompromised; immunodeficiency score index; multiplex PCR assay; seasonal human coronavirus; upper and lower respiratory tract diseaseAdultmedicine.medical_specialtyHCoV-OC43AdolescentDIAGNOSISCHINAHCoV-HKU1BetacoronavirusAll institutes and research themes of the Radboud University Medical Centerstomatognathic systemInternal medicinemedicineMajor ArticleRHINOVIRUSHumansallogeneic hematopoietic stem cell transplantationAgedRetrospective Studiescommunity-acquired respiratory virusbusiness.industryInfantmultiplex PCR assayTransplantationCoronavirus NL63 HumanPARAINFLUENZA VIRUSbusinessimmunodeficiency score indexRespiratory tract
researchProduct